Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Second malignancies in patients with primary central nervous system lymphoma.

Wang J, Pulido JS, O'Neill BP, Johnston PB.

Neuro Oncol. 2015 Jan;17(1):129-35. doi: 10.1093/neuonc/nou105. Epub 2014 Jun 19.

PMID:
24948826
2.

Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.

Walsh KM, Codd V, Smirnov IV, Rice T, Decker PA, Hansen HM, Kollmeyer T, Kosel ML, Molinaro AM, McCoy LS, Bracci PM, Cabriga BS, Pekmezci M, Zheng S, Wiemels JL, Pico AR, Tihan T, Berger MS, Chang SM, Prados MD, Lachance DH, O'Neill BP, Sicotte H, Eckel-Passow JE; ENGAGE Consortium Telomere Group, van der Harst P, Wiencke JK, Samani NJ, Jenkins RB, Wrensch MR.

Nat Genet. 2014 Jul;46(7):731-5. doi: 10.1038/ng.3004. Epub 2014 Jun 8.

3.

Molecular subtypes of glioblastoma are relevant to lower grade glioma.

Guan X, Vengoechea J, Zheng S, Sloan AE, Chen Y, Brat DJ, O'Neill BP, de Groot J, Yust-Katz S, Yung WK, Cohen ML, Aldape KD, Rosenfeld S, Verhaak RG, Barnholtz-Sloan JS.

PLoS One. 2014 Mar 10;9(3):e91216. doi: 10.1371/journal.pone.0091216. eCollection 2014.

4.

The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme.

Wang E, Zhang C, Polavaram N, Liu F, Wu G, Schroeder MA, Lau JS, Mukhopadhyay D, Jiang SW, O'Neill BP, Datta K, Li J.

PLoS One. 2014 Jan 23;9(1):e86102. doi: 10.1371/journal.pone.0086102. eCollection 2014.

5.

[(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.

Flanagan EP, Hunt CH, Lowe V, Mandrekar J, Pittock SJ, O'Neill BP, Keegan BM.

Mayo Clin Proc. 2013 Nov;88(11):1204-12. doi: 10.1016/j.mayocp.2013.07.019.

PMID:
24182701
7.

Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology.

Rice T, Zheng S, Decker PA, Walsh KM, Bracci P, Xiao Y, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Hsuang G, Wiemels JL, Tihan T, Pico AR, Prados MD, Chang SM, Berger MS, Caron A, Fink S, Kollmeyer T, Rynearson A, Voss J, Kosel ML, Fridley BL, Lachance DH, Eckel-Passow JE, Sicotte H, O'Neill BP, Giannini C, Wiencke JK, Jenkins RB, Wrensch MR.

Neuro Oncol. 2013 May;15(5):535-41. doi: 10.1093/neuonc/nos324. Epub 2013 Jan 29.

8.

Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma.

Johnson DR, Sawyer AM, Meyers CA, O'Neill BP, Wefel JS.

Neuro Oncol. 2012 Jun;14(6):808-16. doi: 10.1093/neuonc/nos082. Epub 2012 Apr 16.

9.

SSBP2 variants are associated with survival in glioblastoma patients.

Xiao Y, Decker PA, Rice T, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Wiemels JL, Tihan T, Prados MD, Chang SM, Berger MS, Kosel ML, Fridley BL, Lachance DH, O'Neill BP, Buckner JC, Thompson RC, Nabors LB, Olson JJ, Brem S, Madden MH, Browning JE, Wiencke JK, Egan KM, Jenkins RB, Wrensch MR.

Clin Cancer Res. 2012 Jun 1;18(11):3154-62. doi: 10.1158/1078-0432.CCR-11-2778. Epub 2012 Apr 3.

10.

Secondary intramedullary spinal cord non-Hodgkin's lymphoma.

Flanagan EP, O'Neill BP, Habermann TM, Porter AB, Keegan BM.

J Neurooncol. 2012 May;107(3):575-80. doi: 10.1007/s11060-011-0781-4. Epub 2011 Dec 22.

PMID:
22189600
11.

Glioblastoma survival in the United States before and during the temozolomide era.

Johnson DR, O'Neill BP.

J Neurooncol. 2012 Apr;107(2):359-64. doi: 10.1007/s11060-011-0749-4. Epub 2011 Nov 2.

PMID:
22045118
12.

Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking.

Lachance DH, Yang P, Johnson DR, Decker PA, Kollmeyer TM, McCoy LS, Rice T, Xiao Y, Ali-Osman F, Wang F, Stoddard SM, Sprau DJ, Kosel ML, Wiencke JK, Wiemels JL, Patoka JS, Davis F, McCarthy B, Rynearson AL, Worra JB, Fridley BL, O'Neill BP, Buckner JC, Il'yasova D, Jenkins RB, Wrensch MR.

Am J Epidemiol. 2011 Sep 1;174(5):574-81. doi: 10.1093/aje/kwr124. Epub 2011 Jul 8.

13.

Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens.

Braggio E, McPhail ER, Macon W, Lopes MB, Schiff D, Law M, Fink S, Sprau D, Giannini C, Dogan A, Fonseca R, O'Neill BP.

Clin Cancer Res. 2011 Jul 1;17(13):4245-53. doi: 10.1158/1078-0432.CCR-11-0395. Epub 2011 May 11.

14.

CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.

Laack NN, O'Neill BP, Ballman KV, O'Fallon JR, Carrero XW, Kurtin PJ, Scheithauer BW, Brown PD, Habermann TM, Colgan JP, Gilbert MR, Hawkins RB, Morton RF, Windschitl HE, Fitch TR, Pajon ER Jr; North Central Cancer Treatment Group and Mayo Clinic.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):476-82. doi: 10.1016/j.ijrobp.2010.06.002. Epub 2010 Aug 26.

15.

Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone.

Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, Gastineau DA, Dietz AB.

Neuro Oncol. 2010 Jul;12(7):631-44. doi: 10.1093/neuonc/noq001. Epub 2010 Feb 23.

16.

Racial differences in primary central nervous system lymphoma incidence and survival rates.

Pulido JS, Vierkant RA, Olson JE, Abrey L, Schiff D, O'Neill BP.

Neuro Oncol. 2009 Jun;11(3):318-22. doi: 10.1215/15228517-2008-103. Epub 2009 Mar 9.

17.

Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic.

Schomas DA, Laack NN, Rao RD, Meyer FB, Shaw EG, O'Neill BP, Giannini C, Brown PD.

Neuro Oncol. 2009 Aug;11(4):437-45. doi: 10.1215/15228517-2008-102. Epub 2008 Nov 18.

18.

Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma.

Porter AB, Giannini C, Kaufmann T, Lucchinetti CF, Wu W, Decker PA, Atkinson JL, O'Neill BP.

Ann Neurol. 2008 May;63(5):662-7. doi: 10.1002/ana.21366.

PMID:
18481293
19.

Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients.

Rodriguez FJ, Perry A, Gutmann DH, O'Neill BP, Leonard J, Bryant S, Giannini C.

J Neuropathol Exp Neurol. 2008 Mar;67(3):240-9. doi: 10.1097/NEN.0b013e318165eb75.

20.

EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil.

O'Neill BP, Vernino S, Dogan A, Giannini C.

Neuro Oncol. 2007 Jul;9(3):364-9. Epub 2007 May 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk